About Saints Peptides

Why Saints?

A saint comes with a presumption of virtue. Peptides sometimes collect something similar: a vessel-growth result, a collagen result, a repair result, until the substance seems to acquire a generally benevolent character. I distrust that promotion.

The thymosin β4 stroke experiment in rats gives my objection something specific to stand on. Lower tested amounts improved neurological outcomes, while the largest showed no significant benefit. A promising process still needs the right circumstances. I prefer findings that inconvenience a peptide's reputation.

An intervention can look busy and still leave the important outcome untouched. The GHK-containing hair trial counted something observable in people, then leaves the contribution of each ingredient unresolved. I’m content to credit that bounded result without enlisting it in a much larger story about systemic rejuvenation. Modest credit seems a reasonable bargain for knowing what earned it.

The publication

Saints Peptides is a personal publication about published peptide research. The differences among animal, cell and small human studies absorb me. The uncertainty is often more revealing than the confident summary.

Nothing here is medical advice or an assessment of anyone's health. These experiments offer no basis for an individual treatment decision. The site offers articles and a reading list; it has no products to sell, and it provides no prescribing or appointment service.

Corrections

An attractive explanation has to yield to a better experiment. A misstated outcome or an omitted qualification deserves correction just as much as a wrong number. The contact page identifies the details that help pin down a problem, and the references preserve the source trail.